πŸ‡ΊπŸ‡Έ FDA
Patent

US 7601717

Pterin analogs

granted A61KA61K31/519A61P

Quick answer

US patent 7601717 (Pterin analogs) held by BIOMARIN PHARMACEUTICAL INC. expires Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOMARIN PHARMACEUTICAL INC.
Grant date
Tue Oct 13 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 08 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/519, A61P, A61P13/12, A61P25/00